Green Coating Market Challenges 2025 to 2031: Barriers, Risk Factors, and Strategic Mitigation Approaches
Other |
2026-04-08 12:08:49
Q1: What is MMAF in ADC development?
Monomethyl auristatin F (MMAF) is a potent antimitotic cytotoxic agent commonly used as a payload in antibody–drug conjugates (ADCs) to inhibit microtubule polymerization.
Q2: Why is MMAF widely used as an ADC payload?
MMAF exhibits high cytotoxicity and reduced membrane permeability compared to related compounds, making it effective for targeted cancer therapy. Researchers often utilize MMAF payload for ADC development to study targeted drug delivery systems.